0000778209-21-000258.txt : 20211001 0000778209-21-000258.hdr.sgml : 20211001 20211001080827 ACCESSION NUMBER: 0000778209-21-000258 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20211001 DATE AS OF CHANGE: 20211001 EFFECTIVENESS DATE: 20211001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WRL SERIES LIFE ACCOUNT CENTRAL INDEX KEY: 0000778209 IRS NUMBER: 000000000 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 333-249189 FILM NUMBER: 211297156 BUSINESS ADDRESS: STREET 1: 570 CARILLON PARKWAY CITY: ST PETERSBURG STATE: FL ZIP: 33716 BUSINESS PHONE: 319-355-8366 MAIL ADDRESS: STREET 1: 570 CARILLON PARKWAY CITY: ST PETERSBURG STATE: FL ZIP: 33716 0000778209 S000006588 WRL SERIES LIFE ACCOUNT C000223656 New WRL Freedom Elite Advisor 497 1 497freeeliteadv.htm

SUPPLEMENT DATED OCTOBER 1, 2021
To the
PROSPECTUS DATED MAY 1, 2004-WRL FREEDOM ELITE ADVISORSM
PROSPECTUS DATED MAY 1, 1994-WRL FREEDOM SP PLUS ®
PROSPECTUS DATED MAY 1, 1989- THE EQUITY PROTECTOR®

Issued by
Transamerica Life Insurance Company
WRL Series Life Account


Effective on or about November 1, 2021, based on change to the underlying portfolio, the following name and subadvisor change will occur:

Current Portfolio Name
New Portfolio Name
Current Subadvisor
New Subadvisor
Transamerica International Growth VP
Transamerica International Focus VP
TDAM USA Inc.
Epoch Investment Partners, Inc.

This Supplement updates certain information in the above referenced prospectuses (the ‘‘Prospectuses’’).  Except as indicated in this Supplement, all other information included in the Prospectuses remain unchanged. The terms and section headings we use in this Supplement have the same meaning as in the Prospectuses. We will send you another copy of the applicable Prospectus or any supplement without charge upon request. Please contact our Administrative Office referenced in the Prospectuses.




* * *

This Supplement must be accompanied or preceded by the current Prospectus.
Please read this Supplement carefully and retain it for future reference.